La experiencia del ruido es tan subjetiva como universal. Mientras algunos sonidos pueden ser energizantes y hasta placenteros, otros generan rechazo y malestar. ¿Qué hace que ciertos ruidos sean desagradables? La respuesta se encuentra en una compleja interacción entre las prop …
Charles Hard Townes fue un físico visionario cuya contribución a la ciencia moderna le valió el Premio Nobel de Física en 1964. Su innovador trabajo en la electrónica cuántica no solo dio origen al máser – precursor del láser – sino …
El descubrimiento, en una galaxia espiral como la nuestra, de un agujero negro mucho más masivo y violento de lo que parecía posible en una galaxia de este tipo, hace pensar que en amplios sectores de algunas galaxias quizá no sea posible que haya mundos en cuya superficie prosp …
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for the upcoming oral options will be the sector’s next great challenge.
GLP-1 Injectables Will Soon Be Joined by Orals. Is the Industry Ready to Scale? Read More »
AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to biosimilars and new options enter the market.
Humira Biosimilars Gain Ground as Doctors Adjust And New Therapies Rise Read More »
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.
Dexcom COO on 15-day glucose sensor, Type 2 coverage Read More »
After years of controversy and allegations of doctored data, Cassava is moving on from Alzheimer’s.
Cassava Finally Ends Alzheimer’s Program for Embattled Simufilam Read More »
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” experiment to determine whether 65- and 66-year-olds who received GSK’s shingles vaccine Shingrix have reduced dementia risk.
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia Read More »
The new framework is intended to make postmarket changes easier for products. Experts recommend having a clear roadmap and contacting regulators early.
5 tips for building a predetermined change control plan Read More »
As part of cost-cutting efforts, Alector will let go of about 25 people during the third quarter of 2025 as it focuses on advancing its preclinical and research pipeline. Alector is also continuing clinical-stage work on programs for frontotemporal dementia and Alzheimer’s disease.
Alector Will Cut Staff Again, This Time Laying Off 13% of Workforce Read More »
